This post was originally published on this site
Barclays disclosed on March 28 that it had exceeded a U.S. limit on sales of structured products, triggering a loss and a potential restatement of its 2021 accounts.
“Barclays will continue to evaluate the extent to which it can resume market making in any such individual security,” the bank said on Friday.